Skip to main content
SpringerPlus

Table 1 Baseline patient characteristics

From: Post-treatment neutrophil-to-lymphocyte ratio in predicting prognosis in patients with metastatic clear cell renal cell carcinoma receiving sunitinib as first line therapy

Factors

Distribution

Age*

58.5, 61.0 (49.0 ~ 67.0)

Gender (%)

 

 Male

88 (80.7)

 Female

21 (19.3)

BMI (kg/m2)*

23.3, 23.2 (21.4 ~ 25.1)

ECOG performance status (%)

 

 0

74 (67.9)

 1

31 (28.4)

 2

4 (3.7)

MSKCC risk group (%)

 

 Good

37 (33.9)

 Intermediate

69 (63.3)

 Poor

3 (2.8)

Synchronous metastasis (%)

56 (51.4)

Multiple organ metastasis (%)

52 (47.7)

Hemoglobin (g/dℓ)*

12.7, 12.8 (11.6 ~ 13.9)

Albumin (g/dℓ)*

4.1, 4.2 (3.9 ~ 4.4))

Corrected calcium (mg/dℓ)*

9.5, 9.3 (9.0 ~ 9.6)

Pre-treatment NLR*

2.8, 2.3 (1.5 ~ 3.1)

Post-treatment NLR*

1.4, 1.2 (0.8 ~ 1.7)

  1. *Values are expressed as mean, median (interquartile range).
Back to article page